Mangosteen Supplement as Adjuvant Therapy With Sitagliptin/Metformin in Iraqi Patients With Type 2 Diabetes

NCT07172269 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Diabete Mellitus
Type 2 Diabetes
Obesity Type 2 Diabetes Mellitus
Dyslipidemia in Patients With Diabetes Mellitus
Insulin Resistance

Interventions

DRUG: Sitagliptin + Metformin
DIETARY_SUPPLEMENT: mangosteen supplement
BEHAVIORAL: Lifestyle Management

Sponsor

Mais Qais Hbeeb